Gamma Investing LLC Biomarin Pharmaceutical Inc Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Gamma Investing LLC holds 1,666 shares of BMRN stock, worth $94,728. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,666
Previous 3,129
46.76%
Holding current value
$94,728
Previous $221 Million
58.6%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding BMRN
# of Institutions
671Shares Held
179MCall Options Held
1.21MPut Options Held
850K-
Black Rock Inc. New York, NY22.7MShares$1.29 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.08 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$897 Million0.71% of portfolio
-
Dodge & Cox San Francisco, CA15.1MShares$859 Million0.5% of portfolio
-
Viking Global Investors LP10.8MShares$614 Million2.55% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.6B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...